Cargando…
2-[(18)F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
Autores principales: | Verger, Antoine, Barthel, Henryk, Tolboom, Nelleke, Fraioli, Francesco, Cecchin, Diego, Albert, Nathalie L., van Berckel, Bart, Boellaard, Ronald, Brendel, Matthias, Ekmekcioglu, Ozgul, Semah, Franck, Traub-Weidinger, Tatjana, van de Weehaeghe, Donatienne, Morbelli, Silvia, Guedj, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286958/ https://www.ncbi.nlm.nih.gov/pubmed/35840817 http://dx.doi.org/10.1007/s00259-022-05913-7 |
Ejemplares similares
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
por: Verger, Antoine, et al.
Publicado: (2023) -
EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2021) -
Correction to: EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3
por: Guedj, Eric, et al.
Publicado: (2022) -
COVID-19 and the brain: impact on nuclear medicine in neurology
por: Morbelli, Silvia, et al.
Publicado: (2020) -
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
por: Morbelli, Silvia, et al.
Publicado: (2020)